cholangiocarcinoma

Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study

Frontiers - 01 Jul 2025
Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study ...

Juan W. Valle: Portland Cholangiocarcinoma Symposium Highlights Collaboration for Better Patient Care

Oncodaily - 02 Jul 2025
Juan W. Valle: Portland Cholangiocarcinoma Symposium Highlights Collaboration for Better Patient Care ...

Advancing precision oncology in intrahepatic cholangiocarcinoma

News-Medical - 13 Jun 2025
Advancing precision oncology in intrahepatic cholangiocarcinoma ...

(VIDEO) A rare cancer. A rare weapon. Curtis Jackson’s inspiring story of survival

Mayo Clinic News Network - 02 Jul 2025
(VIDEO) A rare cancer. A rare weapon. Curtis Jackson’s inspiring story of survival ...

Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage | Scientific Reports

Nature - 16 Jan 2025
Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage | Scientific Reports ...

First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort

ScienceDirect.com - 20 Nov 2024
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort ...

Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial

Cleveland Clinic - 05 Jun 2025
Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial ...

High-Efficiency Cell-Type Proteomics Strategy Deciphers Cholangiocarcinoma Fibrosis-Associated Pathological Heterogeneity

ACS Publications - 03 Mar 2025
High-Efficiency Cell-Type Proteomics Strategy Deciphers Cholangiocarcinoma Fibrosis-Associated Pathological Heterogeneity ...

Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids

Journal of Translational Medicine - 09 Jan 2025
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids ...

Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes

The Lancet - 24 Nov 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes ...

Advances in surgery for cholangiocarcinoma: Overcoming risks and expanding treatment options

Mayo Clinic - 10 Jun 2025
Advances in surgery for cholangiocarcinoma: Overcoming risks and expanding treatment options ...

Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation

Nature - 03 Apr 2025
Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation ...

Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma

ScienceDirect.com - 03 Apr 2025
Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma ...

Case report: Rare observation of thyroid-like cholangiocarcinoma

Frontiers - 27 Dec 2024
Case report: Rare observation of thyroid-like cholangiocarcinoma ...

Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability

Nature - 09 Apr 2025
Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability ...

TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8 + T cell exhaustion: implications for immunotherapy

Nature - 12 Feb 2025
TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8 + T cell exhaustion: implications for immunotherapy ...